17 related articles for article (PubMed ID: 38561007)
1. Preliminary outcomes of endovascular treatment of moyamoya disease.
Li XY; Tian YY; Li CH; Wang JW; Li H; Liu JF; Gao BL
Neurologia (Engl Ed); 2024; 39(6):449-456. PubMed ID: 38901925
[TBL] [Abstract][Full Text] [Related]
2. Self-expanding versus balloon expandable stent for intracranial arterial stenosis: A systematic review and meta-analysis.
Qureshi AI; Lodhi A; Ma X; Ahmed R; Kwok CS; Maqsood H; Liaqat J; Hassan AE; Siddiq F; Gomez CR; Suri MFK
J Neuroimaging; 2024; 34(3):295-307. PubMed ID: 38225680
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a clinical prediction model for ischemic stroke recurrence after successful stent implantation in symptomatic intracranial atherosclerotic stenosis.
Nitasha F; Samiullah F; Hafeezullah F
J Clin Neurosci; 2024 Jul; 125():167. PubMed ID: 38815303
[No Abstract] [Full Text] [Related]
4. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
Li A; Ye Z; Zhou W; Qin C
Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
[TBL] [Abstract][Full Text] [Related]
6. [A long-term follow-up results of Enterprise stent in treatment of severe symptomatic basilar artery atherosclerotic stenosis].
Zhao Y; Jin M; Liu Q; Liu D; Chen J; Du B
Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):372-6. PubMed ID: 27143187
[TBL] [Abstract][Full Text] [Related]
7. Endovascular treatment of symptomatic intracranial arterial stenosis: six-year experience in a single-center series of 42 consecutive patients with acute and mid-term results.
Costalat V; Maldonado IL; Zerlauth JB; Menjot N; Riquelme C; Machi P; Vendrell JF; Bonafé A
Neurosurgery; 2010 Dec; 67(6):1505-13; discussion 1513-4. PubMed ID: 21107181
[TBL] [Abstract][Full Text] [Related]
8. Thirty-Day Outcomes of the Enterprise Stent in Treating Hypoperfusion of Symptomatic Intracranial Stenosis.
Huang CM; Hong YF; Xing SH; Xu K; Xu CK; Zhang WJ; Li H; Zhang PF; Cai CW
World Neurosurg; 2019 Sep; 129():e429-e435. PubMed ID: 31150855
[TBL] [Abstract][Full Text] [Related]
9. Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation.
Ma L; Zhang H; Duan G; Luo Y; Zhang X; Lu Z; Chen Z; Yu L; Zhang T; Xu Y; Li J
Neurol Res; 2024 Jun; 46(6):538-543. PubMed ID: 38561007
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
